Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Abdominal Aortic Aneurysm Inhibition
2018-004289-33Phase 2Active
- Sponsor
- Uppsala University
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of metformin in abdominal aortic aneurysm (AAA), sponsored by Uppsala University. Primary endpoint: AAA growth rate over 5 years. Started Jul 2019; status: active.
02
Drugs
metformin
03
Conditions
abdominal aortic aneurysm (AAA)
Beyond the preview
Go deeper on 2018-004289-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004289-33.